2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

被引：21

作者：

Yeon, Jong Eun ^{[1
]}

Kim, In Hee ^{[2
]}

Lee, Jung Il ^{[3
]}

Kim, Kyung-Ah ^{[4
]}

Gwak, Geum-Youn ^{[5
]}

Kim, Ji Hoon ^{[1
]}

Kim, Kang Mo ^{[6
]}

Jang, Jeong Won ^{[7
]}

Kim, Do Young ^{[3
]}

Yoon, Ki Tae ^{[8
]}

机构：

[1] Korea Univ, Coll Med, Seoul, South Korea

[2] Chonbuk Natl Univ, Med Sch, Jeonju, South Korea

[3] Yonsei Univ, Coll Med, Seoul, South Korea

[4] Inje Univ, Coll Med, Gimhae, South Korea

[5] Sungkyunkwan Univ, Sch Med, Seoul, South Korea

[6] Univ Ulsan, Coll Med, Ulsan, South Korea

[7] Catholic Univ Korea, Coll Med, Seoul, South Korea

[8] Pusan Natl Univ, Sch Med, Busan, South Korea

来源：

CLINICAL AND MOLECULAR HEPATOLOGY | 2018年 / 24卷 / 03期

关键词：

Chronic hepatitis C; Treatment; Direct acting antivirals; Guidelines; VIRUS GENOTYPE 1; SOFOSBUVIR PLUS RIBAVIRIN; TREATMENT-EXPERIENCED PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTING ANTIVIRAL THERAPY; ADVANCED LIVER-DISEASE; RESISTANCE-ASSOCIATED SUBSTITUTIONS; PREVIOUSLY UNTREATED PATIENTS; HIV/HCV-COINFECTED PATIENTS;

D O I：

10.3350/cmh.2018.1004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：169 / 229

页数：61

共 240 条

[11] ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection [J].

Andreone, Pietro ;

Colombo, Massimo G. ;

Enejosa, Jeffrey V. ;

Koksal, Iftihar ;

Ferenci, Peter ;

Maieron, Andreas ;

Muellhaupt, Beat ;

Horsmans, Yves ;

Weiland, Ola ;

Reesink, Henk W. ;

Rodrigues, Lino, Jr. ;

Hu, Yiran B. ;

Podsadecki, Thomas ;

Bernstein, Barry .

GASTROENTEROLOGY, 2014, 147 (02) :359-+

[12]

[Anonymous], 2017, HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

[13]

[Anonymous], GUIDELINES USE ANTIR

[14] Natural history of hepatitis B and C in renal allograft recipients [J].

Aroldi, A ;

Lampertico, P ;

Montagnino, G ;

Passerini, P ;

Villa, M ;

Campise, MR ;

Lunghi, G ;

Tarantino, A ;

Cesana, BM ;

Messa, P ;

Ponticelli, C .

TRANSPLANTATION, 2005, 79 (09) :1132-1136

[15]

Asselah T, 2016, HEPATOLOGY, V64, p63A

[16]

Asselah T, 2015, HEPATOLOGY, V62, p340A

[17] Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts [J].

Avidan, Neumann U. ;

Goldstein, Deborah ;

Rozenberg, Lynn ;

McLaughlin, Maiy ;

Ferenci, Peter ;

Masur, Henry ;

Buti, Maria ;

Fauci, Anthony S. ;

Polis, Michael A. ;

Kottilil, Shyam .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (04) :452-458

[18] Real-World Effectiveness of Ledipasvir/Sofosbuvir in 4,365 Treatment-Naive, Genotype 1 Hepatitis C-Infected Patients [J].

Backus, Lisa I. ;

Belperio, Pamela S. ;

Shahoumian, Troy A. ;

Loomis, Timothy P. ;

Mole, Larry A. .

HEPATOLOGY, 2016, 64 (02) :405-414

[19] The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 1 Infection [J].

Balistreri, William F. ;

Murray, Karen F. ;

Rosenthal, Philip ;

Bansal, Sanjay ;

Lin, Chuan-Hao ;

Kersey, Kathryn ;

Massetto, Benedetta ;

Zhu, Yanni ;

Kanwar, Bittoo ;

German, Polina ;

Svarovskaia, Evguenia ;

Brainard, Diana M. ;

Wen, Jessica ;

Gonzalez-Peralta, Regino P. ;

Jonas, Maureen M. ;

Schwarz, Kathleen .

HEPATOLOGY, 2017, 66 (02) :371-378

[20] ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients [J].

Belli, Luca S. ;

Duvoux, Christophe ;

Berenguer, Marina ;

Berg, Thomas ;

Coilly, Audrey ;

Colle, Isabelle ;

Fagiuoli, Stefano ;

Khoo, Saye ;

Pageaux, Georges Philippe ;

Puoti, Massimo ;

Samuel, Didier ;

Strazzabosco, Mario .

JOURNAL OF HEPATOLOGY, 2017, 67 (03) :585-602

← 1 2 3 4 5 6 7 8 9 10 →